Wojciech is an experimental biologist. During his PhD (2010-2018), he used mouse and human induced pluripotent stem cells (iPSC) as a model for studying neurodevelopmental component of Huntington disease, and as a model for experimental, autologous cell therapy of Huntington disease. In 2015 he had a 3-month stay in prof. Austin Smith’s group at Cambridge Stem Cell Institute (UK), where he took part in the initial research on human naïve pluripotent stem cells (PSCs) differentiation capacity.

Following his fascination in developmental biology he joined Borowiak lab for his post-doc in 2018, were he studies intrinsic and extrinsic (microenvironment) drivers of human pancreas development, with the aim to use this knowledge for efficient generation of pancreatic beta-cells for cell therapy of diabetes. For this he use human PSC 3D pancreatic differentiation, CRISPR/Cas9 and lightsheet imaging technologies. In his research he also used patient-derived iPSCs to model developmental defects in rare monogenic diabetes (MODY) and to study SARS-CoV-2 infectivity of pancreatic cells. Since 2022 he is leading the NCN Sonata project.

When not in the lab he tries to spend some valuable time with his family. He enjoys mountain trekking, traveling (self-made camper van), skiing and underwater hockey.